Pulse Biosciences, Inc. PLSE Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s cash provided by (used in) investing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s cash provided by (used in) investing activity, including discontinued operation?
- Pulse Biosciences, Inc. (PLSE) reported cash provided by (used in) investing activity, including discontinued operation of -$33K in Q1 2026.
- How has Pulse Biosciences, Inc.'s cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
- Pulse Biosciences, Inc.'s cash provided by (used in) investing activity, including discontinued operation increased by 26.7% year-over-year, from -$45K to -$33K.
- What is the long-term trend for Pulse Biosciences, Inc.'s cash provided by (used in) investing activity, including discontinued operation?
- Over 3 years (2022 to 2025), Pulse Biosciences, Inc.'s cash provided by (used in) investing activity, including discontinued operation has grown at a -5.8% compound annual growth rate (CAGR), from -$401K to -$335K.
- What does cash provided by (used in) investing activity, including discontinued operation mean?
- The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.